Impact of dialysis therapy on insulin resistance in end-stage renal disease: Comparison of haemodialysis and continuous ambulatory peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 15, Issue 1, 2000, Pages 65-70

  Kobayashi, Shuzo ^a   Maejima, Syunichi ^a   Ikeda, Toshio ^b   Nagase, Mitsumasa ^c  

^a SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

^b Kanto Teishin Hospital   (Japan)

^c TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Continuous ambulatory peritoneal dialysis; Glucose metabolism; Haemodialysis; Insulin resistance; Uraemia

Indexed keywords

BICARBONATE; GLUCOSE; HUMARIN R; INSULIN; UNCLASSIFIED DRUG; UREA;

ADULT; AGED; ARTICLE; ARTIFICIAL PANCREAS; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GLUCOSE CLAMP TECHNIQUE; HEMATOCRIT; HEMODIALYSIS; HUMAN; INSULIN RESISTANCE; INTERMETHOD COMPARISON; KIDNEY FAILURE; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; UREA NITROGEN BLOOD LEVEL; UREMIA;

EID: 0033965172     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.1.65     Document Type: Article

References (40)

1. Feldman HA, Singer I. Endocrinology and metabolism in uremia and dialysis: a clinical review. Medicine 1974; 54: 345-376
2. Linder A, Charra B, Sherpard DJ, Scribner BH. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 1974; 290: 697-701
3. Stout RW. Diabetes and atherosclerosis - the role of insulin. Diabetologia 1979; 16: 141-148
4. Moorhead JF, Chan MK, Varghese Z. The role of abnormalities of lipid metabolism in the progression of renal disease. In: Brenner BM, Stein JH eds. The Progressive Nature of Renal Disease, Churchill Livingstone, New York: 1986: 133-149
5. Ikeda T, Gomi T, Hirawa N, Sakurai J, Yoshikawa N. Improvement of insulin sensitivity contributes to blood pressure reduction after weight loss in hypertensive subjects with obesity. Hypertension 1996; 27: 1180-1186
6. Mak RHK, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-382
7. Neubaurer E. Über hyperglykaemia bei hochdrucknephritis und die beziehungen zwischen glykaemie und glycosurie beim diabetes mellitus. Biochem Z 1910; 25: 285-298
8. DeFronzo RA, Andres R, Edgar P. Walker WG. Carbohydrate metabolism in uremia. Medicine 1973; 52: 469-481
9. DeFronzo RA, Alvestrand A, Smith D, Hendlerm R, Hendler E, Wahren J. Insulin resistance in uremia. J Clin Invest 1981; 65: 563-568
10. Mak RHK. Renal disease, insulin resistance and glucose intolerance. Diabetes 1994; 2: 19-28
11. DeFronzo RA, Tobin JD, Rowe JW, Andres R. Glucose intolerance in uremia. Quantification of pancreatic beta cell sensitivity to glucose and tissue sensitivity to insulin. J Clin Invest 1978; 63: 425-435
12. Smith D, DeFronzo RA. Insulin resistance in uremia mediated by postbinding defects. Kidney Int 1982; 22: 54-62
13. MaK RHK. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol 1996; 270: F839-F894
14. MaK RHK. 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992; 41: 1048-1054
15. Borissova AM, Djambazova A, Todorov K, Dakovska L, Tankova T, Kirilov G. Effect of erythropoietin on the metabolic state and peripheral insulin sensitivity in diabetic patients on hemodialysis.Nephrol Dial Transplant 1993; 8: 93-95
16. Kokot F, Wiecek A, Grzeszczak W. Influence of erythropoietin treatment on endocrine abnormalities in hemodialyzed patients. In: Baldamus CA, Koch KM, Scigalla P, Wieczorek L, eds. Erythropoietin: From Molecular Structure to Clinical Application, Karger, Basel: 1990: 257-272
17. Chagnac A, Korzets A, Zevin D, Korzets A, Hirsh J, Gafter U, Levi J. Effect of erythropoietin on glucose tolerance in hemodialysis patients. Clin Nephrol 1994; 42: 398-400
18. Allegra V, Mengozzi G, D'Achille F. Glucose-induced insulin secretion in uremia: role of anemia. Nephron 1992; 62: 246-47
19. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol1979; 237: E21-E223
20. McGuire EAH, Helderman JH, Tobin JD, Andres R, Berman M. Effect of arterial versus venous sampling on analysis of glucose kinetics in man. J Appl Physiol 1976; 41: 565-573
21. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-618
22. Maloff BL, McCaleb ML, Lockwood DH. Cellular basis of insulin resistance in chronic uremia. Am J Physiol 1983; 245: E178-E184
23. Rocic B, Breyer D, Granic M, Milutinovic S. The effect of guanidino substrances from uremic plasma on insulin binding to erythrocyte receptors in uremia. Hormone Metab Res 1991; 23: 490-494
24. Mak RHK: Insulin resistance in uremia: effect of dialysis modality. Pediatr Res 1995; 40: 304-308
25. Heaton A, Taylor R, Johnston DG, Ward MK, Wilkinson R, Alberti KGMM. Hepatic and peripheral insulin action in chronic renal failure before and during continuous ambulatory peritoneal dialysis. Clin Sci 1989; 77: 383-388
26. Delarue J, Maingourd C, Couet C, Vidal S, Begros P, Lamisse F. Effect of oral glucose on intermediary metabolism in continuous ambulatory peritoneal dialysis patients versus healthy subjects. Peritoneal Dial Int 1998; 18: 505-511
27. Mak RHK, DeFronzo RA. Glucose and insulin metabolism in uremia. Nephron 1992; 61: 377-382
28. Hampers CL, Soeldner LS, Doak PB, Merrill JP. Effect of chronic renal failure and hemodialysis on carbohydrate metabolism. J Clin Invest 1966; 45: 1719-1731
29. Hutchings RH, Hegstrom RM, Scribner BH. Glucose intolerance in patients on long-term intermittent dialysis. Ann Intern Med 1966; 65: 275-285
30. Wada T, Miyata T, Kurokawa K. Implication of carbonyl stress in long-term uremic complications. Nephrol Dial Transplant 1999; 14 [Suppl 1]: 79-81
31. Dzuric R, Spustova V. Accumulated end products participate in glucose intolerance and insulin resistance in uremia. Nephron 1993; 65: 481
32. McCaleb ML, Izzo MS, Lockwood DH. Characterization and partial purification of a factor from uremic human serum that induces insulin resistance. J Clin Invest 1985; 75: 391-396
33. MaK RHK, Turner C, Thompson T, Haycock GB, Chantler C. The effect of dietary protein restriction and amino acid/ketoacid supplements on glucose metabolism in uremic children. J Clin Endocrinol Metab 1986; 63: 985-989
34. Walke BG, Phear DN, Martin PIR, Baird CW. Inhibition of insulin action by acidosis. Lancet 1973; 2: 964-965
35. Feldman HA, Singer I. Endocrinology and metabolism in uremia and dialysis: a clinical review. Medicine 1975; 54: 345-376
36. Mak RHK, Turner C, Haycock GB, Chantler C. Secondary hyperthyroidism and glucose intolerance in children with uremia. Kidney Int 1983; 16 [Suppl 24]: S1228-S1233
37. Boulanger CM, Tanne FC, Bea ML, Hahn AW, Werner A, Luscher TF. Oxidized low density lipoproteins induce mRNA expression and release of endothelin from the human plus porcine endothelium. Circulation Res 1992; 70: 1191-1197
38. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothclium-dependent arterial relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990; 344: 160-162
39. Stenvinkel P, Ottosson-Seeberger A, Alvestrand A. Renal hemodynamics and sodium handling in moderate renal insufficiency: the role of insulin resistance and dyslipidemia. J Am Soc Nephrol 1995; 5: 1751-1760
40. Goldberg AP, Hagberg JM, Delmez JA, Haynes ME, Harter HR. The metabolic effects of exercise training in hemodialysis patients. Kidney Int 1980; 18: 754-761